↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

64 / 1,666 drugs found* Show info (disease name, etc.) on mouse-over.
 No.   DrugBank   薬物名(臨床試験情報から抽出)   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   Abatacept  27件: Abatacept; Abatacept injection; Bms 188667 (abatacept); Abatacept (aba) + methotrexate (mtx), double-blind (db); Abatacept (bms-188667); Abatacept (iv); Abatacept + csdmard; Abatacept + methotrexate; Abatacept + vaccines; Abatacept placebo; Abatacept prefilled syringe; Abatacept, rituximab or tocilizumab; Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept); Decrease tocilizumab, abatacept; Double-blind abatacept; Intravenous (iv) abatacept; Iv abatacept; Open-label abatacept; Orencia (abatacept); Orencia abatacept; Subcutaneous (sc) abatacept; Subcutaneous abatacept; Subcutaneous(sc) abatacept; Tocilizumab, abatacept; Abatacept subcutaneous; Abatacept sc; Abatacept (aba);   D03203   2件: CD80, CD86   3件: Cell adhesion molecules (CAMs), Intestinal immune network for IgA production, Rheumatoid arthritis   24件:
11,
13,
19,
41,
44,
46,
49,
50,
51,
53,
55,
60,
65,
84,
93,
96,
97,
107,
164,
222,
271,
284,
285,
300
 2   Acyclovir  1件: Acyclovir;   D00222   -   -   5件:
13,
28,
46,
53,
60
 3   Adenosine  6件: 2-cda, 2-chloro-2’-deoxy-beta-d-adenosine; 2-cda, 2-chloro-2’-deoxy-ß-d-adenosine; 2-chloro-2'-deoxyadenosine, 2cda; 2-chloro-2’-deoxyadenosine (2-cda); Adenosine; Autologous ex vivo gene therapy products based on the efs lv encoding for the human adenosine deaminase (ada) gene (efs-ada lv);   D00045   4件: ADORA1, ADORA2A, ADORA2B, ADORA3   2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction   5件:
13,
46,
53,
58,
65
 4   Alginic acid  1件: Alginic acid;   D02324   -   -   3件:
51,
53,
299
 5   BMS-986142  5件: Bms-986142; Bms-986142 200mg; Bms-986142 350mg; Methotrexate, leucovorin and bms-986142; Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142;   -   -   -   2件:
46,
53
 6   Baminercept  3件: Baminercept; Baminercept alfa; Baminercept alfa (bg9924);   D08866   1件: LTB   3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis   4件:
13,
46,
53,
97
 7   Belimumab  21件: Belimumab; Benlysta (belimumab); Benlysta® (belimumab); Belimumab 10 mg/kg; Belimumab 1 mg/kg; Belimumab 4 mg/kg; Belimumab 10 mg/kg plus standard therapy; Belimumab 100 mg sc; Belimumab 10mg/kg; Belimumab 200 mg sc; Belimumab 200 mg/ml; Belimumab for iv; Belimumab for sc; Belimumab injection; Belimumab or benlysta; Belimumab plus early vaccination; Belimumab plus late vaccination; Benlysta™ (belimumab); Sc belimumab 200 mg; Belimumab 10 mg; Gsk1550188 (belimumab);   D03068   1件: TNFSF13B   2件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway   8件:
11,
43,
44,
46,
49,
51,
53,
222
 8   Boscalid  0件:   -   -   -   1件:
53
 9   Bupivacaine  9件: Bupivacaine; Bupivacaine hydrochloride; Levobupivacaine; Liposomal bupivacaine; Bupivacaine/epinephrine/dexamethasone; Lap tap bupivacaine/epinephrine; Us tap bupivacaine/epinephrine; Bupivacaine injection 0.5%; Bupivacaine & triamcinolone acetonide;   D01450
 D07552 
 1件: SCN1A   1件: Dopaminergic synapse   7件:
46,
53,
70,
96,
168,
226,
298
 10   Cevimeline  1件: Cevimeline;   D00661
 D07667 
 1件: CHRM3   3件: Cholinergic synapse, Neuroactive ligand-receptor interaction, Salivary secretion   1件:
53
 11   Cholecalciferol  9件: Cholecalciferol; Cholecalciferol, vitamin d3; Calcium and cholecalciferol; Cholecalciferol and c. xanthorrhiza; Cholecalciferol 10,000 iu; Cholecalciferol 400 iu; Cholecalciferol concentrate; 5000 iu of cholecalciferol; Cholecalciferol (vitamin d3);   D00188   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   15件:
6,
13,
19,
20,
34,
46,
49,
53,
60,
65,
96,
97,
228,
298,
299
 12   Ciclosporin  7件: Ciclosporin; Ciclosporina; Ciclosporine; Aerolised liposomal ciclosporin a; Ciclosporin (ciclosporinium); Ciclosporin a; Ciclosporine, ciclosporina;   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   44件:
11,
14,
19,
20,
26,
28,
36,
38,
39,
40,
41,
42,
45,
46,
49,
50,
53,
55,
56,
58,
60,
61,
62,
63,
64,
65,
90,
95,
97,
113,
162,
164,
222,
223,
226,
228,
234,
269,
274,
283,
284,
285,
302,
326
 13   Citric acid  3件: Citric acid; Citric acid based mouthwash; Sodium picosulfate, magnesium oxide and citric acid;   D00037
 D01222 
 -   -   4件:
46,
53,
245,
291
 14   Dexamethasone  35件: Dexamethasone; Dexamethasone soduim phosphate; Lenalidomide and dexamethasone; Lenalidomide+dexamethasone; Lenalidomide, dexamethasone; Bortezomib/dexamethasone (bd), followed by autologous stc & maintenance bortezomib/dexamethasone; Cyclophosphamide, bortezomib, dexamethasone; Cyclophosphamide, bortezomib, dexamethasone plus daratumumab; Dexamethasone, 40 mg; Lenalidomide, dexamethasone and cyclophosphamide; Melphalan, thalidomide and dexamethasone; Pomalidomide and dexamethasone; Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine; Dexamethasone (50mg 1dd6, 3 consecutive days/month); Control intervention (no dexamethasone); Intraarticular dexamethasone; Intravenous dexamethasone 1 mg; Peri-neural dexamethasone 1 mg; Dexamethasone parotid irrigation; Dexamethasone (1 cycle); Dexamethasone (4 cycles); Dexamethasone abcur; Dexamethasone and rituximab; High dose dexamethasone pulses; Dexamethasone sodium phosphate; Dexamethasone sodium phosphate ph. eur.; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Dexamethasone 0.5mg tablet; Dexamethasone 2mg tablets; Dexamethasone 0,5mg; Bupivacaine/epinephrine/dexamethasone; Dexamethasone sodium phosphate 250 mg/ 10 ml; Dexamethasone 21-phosphate; Mmf and dexamethasone; Dexamethasone sodium phosphate 250 mg/10 ml solution;   D00292
 D00975
 D01510
 D01615
 D01632
 D01948
 D02174
 D02591
 D02592 
 1件: NR3C1   1件: Neuroactive ligand-receptor interaction   20件:
13,
16,
28,
35,
46,
53,
63,
65,
70,
74,
75,
81,
83,
84,
90,
96,
97,
222,
296,
299
 15   Dornase alfa  4件: Dornase alfa; Dornase alfa (pulmozyme); Dornase alfa [pulmozyme®]; Pulmozyme (dornase alfa);   D03896   -   -   2件:
53,
299
 16   Efalizumab  1件: Efalizumab;   D03959   1件: ITGAL   2件: Cell adhesion molecules (CAMs), Natural killer cell mediated cytotoxicity   9件:
11,
13,
37,
46,
49,
53,
61,
95,
96
 17   Estetrol  1件: Estetrol;   D11513
 D11514 
 2件: ESR1, ESR2   1件: Estrogen signaling pathway   1件:
53
 18   Etanercept  39件: Etanercept; Enbrel (etanercept); Etanercept 50 mg solution for injection; 50 mg etanercept; Anti-tnf therapy (etanercept or adalimumab); Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept); Commercial formulation etanercept; Etanercept (enbrel); Etanercept (enbreltm); Etanercept + methotrexate; Etanercept , methotrexate; Etanercept / autoinjector a; Etanercept 50mg; Etanercept biosimilar; Etanercept liquid; Etanercept or adalimumab; Etanercept pre-filled syringe sq injection; Etanercept treatment; Etanercept via autoinjector a; Etanercept via autoinjector b; Etanercept, other biologics, disease-modifying antirheumatic drugs (dmards), etc; Infliximab, etanercept; Infliximab, etanercept, adalimumab; Methotrexate - etanercept - prednisolone arm; New formulation etanercept; Phase 1: etanercept; Reumatocept (etanercept); Sb4 (etanercept biosimilar); Sb4 (proposed biosimilar to etanercept); Tnf blockers (infliximab, adalimumab, etanercept); Tumor necrosis factor inhibitor (etanercept, infliximab, adalimumab, and golimumab); Etanercept, methotrexate, prednisolone; Adalimumab, etanercept, golimumab or infliximab; Etanercept (50mg per week); Etanercept (50mg per week, for 2 weeks); Etanercept (50mg per week, for 4 weeks); Etanercept (full-dose); Etanercept (half-dose); Tapering or discontinuation of etanercept;   D00742   2件: LTA, TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   15件:
15,
28,
35,
38,
39,
46,
50,
53,
56,
60,
85,
228,
271,
285,
298
 19   Ethanol  14件: Endocannabinoid palmitoylethanolamide (pea); Palmitoylethanolamide; Treprostinil diethanolamine; Ut-15c (treprostinil diethanolamine); Ut-15c sr (treprostinil diethanolamine); Andrographis paniculata (ethanol extract); Ethanol; Ethanol (96 per cent); Ethanol 96% gel; Ethanol 98% solution; Ethanol bp; Ethanol gel; Ethanolamine; Ethanolamine oleate;   D00068
 D02798
 D04855
 D06542 
 -   -   49件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
58,
61,
63,
64,
65,
66,
81,
84,
85,
86,
88,
95,
96,
97,
113,
145,
162,
164,
222,
224,
228,
251,
279,
280,
283,
284,
285,
288,
298,
299,
300,
331
 20   Filgotinib  4件: Filgotinib; Inn - filgotinib; Proposed inn - filgotinib; Propsoed inn - filgotinib;   D10871   1件: JAK1   3件: JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   6件:
46,
53,
96,
97,
222,
271
 21   Fludeoxyglucose F-18  0件:   -   -   -   8件:
6,
13,
34,
46,
53,
84,
127,
300
 22   Gadoteric acid  1件: Gadoteric acid;   D08007   -   -   2件:
13,
53
 23   Ginseng  4件: American ginseng; American ginseng extract ht-1001; Ginseng; Korean red ginseng;   D06772   -   -   3件:
13,
46,
53
 24   Glycerin  1件: Glycerine;   D00028   -   -   6件:
6,
13,
53,
265,
316,
317
 25   Green olive  0件:   -   -   -   3件:
13,
49,
53
 26   Hyaluronic acid  5件: Hyaluronic acid; Standard care hyaluronic acid eye drops; Hyaluronic acid and chondroitin sulfate; Hyaluronic acid/chondroitin sulfate; Hyaluronic acid inhalation solution;   D08043   -   -   7件:
46,
53,
70,
97,
226,
231,
299
 27   Hydrocortisone  22件: Hydrocortisone; Hydrocortisone cream; Hydrocortisone cream 1%; Hydrocortisone cream 10mg/g fna fagron; Subcutaneous hydrocortisone 10mg; Hydrocortisone sodium phosphate; Hydrocortisone takeda, tabletter; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Dual release hydrocortisone (plenadren); Hydrocortisone (solucortef); Hydrocortisone 10mg tablet; Hydrocortisone 20mg tablets; Hydrocortisone modified release capsules; Hydrocortisone sodium acetate; Subcutaneous hydrocortisone; Cortef (hydrocortisone); Hydrocortisone efcortesol & solu-cortef; Hydrocortisone roussel; Solu-cortef (hydrocortisone); Combination oral budesonide and rectal hydrocortisone; Hydrocortisone sodium succinate; Mesalazine with hydrocortisone sodium succinate;   D00088   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   8件:
6,
53,
75,
78,
81,
83,
97,
299
 28   Hydrocortisone acetate  0件:   D00165   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   8件:
6,
53,
75,
78,
81,
83,
97,
299
 29   Hydroxychloroquine  16件: Hydroxychloroquine; Hydroxychloroquine sulfate; Leflunomide-sulfasalazine-hydroxychloroquine; Methotrexate + salazopyrine + hydroxychloroquine administration; Methotrexate-sulfasalazine-hydroxychloroquine; Sulphasalazine + hydroxychloroquine or prednisolone; Hydroxychloroquine (z0188); Hydroxychloroquine high; Hydroxychloroquine or chloroquine; Hydroxychloroquine reduced; Versus hydroxychloroquine; Hydroxychloroquine + prednisone; Sirolimus and hydroxychloroquine; Hydroxychloroquine higher dose; Hydroxychloroquine lower dose; Hydroxychloroquine sulphate;   D08050   -   -   18件:
13,
41,
46,
48,
49,
53,
56,
66,
84,
89,
90,
96,
222,
234,
254,
271,
298,
299
 30   Iguratimod  2件: Iguratimod; Iguratimod (careram);   D01146   1件: NFKB1   2件: NF-kappa B signaling pathway, Osteoclast differentiation   3件:
46,
53,
271
 31   Lanraplenib  1件: Lanraplenib;   D11596   -   -   2件:
53,
222
 32   Leflunomide  10件: Leflunomide; Leflunomide 10mg tab; Leflunomide (permitted, not necessary); Leflunomide 20 mg tablets (geneva pharmaceutical); Leflunomide 20mg tab; Leflunomide-sulfasalazine-hydroxychloroquine; Non-mtx dmards (e.g. sulfasalazine, leflunomide, bucillamine, tacrolimus, or mizoribin); Leflunomide mylan; Leflunomide 20 mg+prednisone 0.5mg/kg/d; Leflunomide(lef);   D00749   1件: DHODH   1件: Pyrimidine metabolism   10件:
11,
40,
46,
49,
53,
66,
162,
224,
271,
300
 33   Levocarnitine  4件: Levocarnitine; Valproate, levocarnitine; Valproic acid and levocarnitine; Levocarnitine propyl hydrochloride;   D02030
 D02176
 D04713 
 -   -   10件:
3,
5,
13,
53,
58,
96,
97,
265,
298,
316
 34   Lulizumab pegol  1件: Lulizumab pegol;   -   -   -   2件:
49,
53
 35   Methotrexate  81件: Methotrexate; Intrathecal methotrexate; Methotrexate treatment; Mycophenolate mofetil,methotrexate; Methotrexate 2.5 mg; Methotrexate 25 mg; Abatacept (aba) + methotrexate (mtx), double-blind (db); Abatacept + methotrexate; Adalimumab with methotrexate; Bms-582949 and methotrexate; Certolizumab pegol + methotrexate (mtx); Cp-690,550 + methotrexate; Etanercept + methotrexate; Etanercept , methotrexate; Infliximab + methotrexate (mtx); Infliximab, methylprednisolone, methotrexate; Methotrexate 'lederle' 2,5mg tablets; Methotrexate 'lederle' 2.5mg tablets; Methotrexate (metoject® prefilled pen); Methotrexate (mtx); Methotrexate + biologic administration; Methotrexate + infliximab; Methotrexate + methylprednisolone; Methotrexate + salazopyrine + hydroxychloroquine administration; Methotrexate - amneal; Methotrexate - dava; Methotrexate - delay; Methotrexate - etanercept - prednisolone arm; Methotrexate - immediate; Methotrexate 2.5 mg tablets; Methotrexate 2.5mg tablets; Methotrexate 2.5mg tablets bp; Methotrexate 50mg/ml solution for injection, pre-filled syringe; Methotrexate as methotrexate disodium; Methotrexate capsules; Methotrexate disodium; Methotrexate pfizer 2,5 mg tabletter; Methotrexate placebo; Methotrexate plus enbrel or enbrel alone; Methotrexate plus erb-041 for 12 weeks; Methotrexate plus sulfasalazine; Methotrexate pre-filled pen; Methotrexate prefilled pen; Methotrexate prefilled syringe; Methotrexate sodium; Methotrexate sodium 2.5mg tablets; Methotrexate sodium tablets 2.5 mg; Methotrexate(mtx); Methotrexate(mtx) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol.; Methotrexate(necessary); Methotrexate*100cpr 2,5mg; Methotrexate, leucovorin and bms-986142; Methotrexate,adalimumab; Methotrexate-lachema; Methotrexate-sulfasalazine-hydroxychloroquine; Methotrexate® 2.5 mg tablets; Mp-435(dose1) + methotrexate; Oral methotrexate; Phase 1: methotrexate; Response to anakinra associated with methotrexate; Response to infliximab associated with methotrexate; Stable weekly dose of methotrexate; Tacrolimus with methotrexate; Tasocitinib plus methotrexate; Tocilizumab + methotrexate(mtx); Tocilizumab+methotrexate(mtx); Tofacitinib with methotrexate; Tofacitinib without methotrexate; Urine samples taken to measure methotrexate and its major metabolite 7-oh-methotrexate level; Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate); Methotrexate and folic acid; Methotrexate lachema 5inj. sol; Etanercept, methotrexate, prednisolone; Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf; Azathioprine or methotrexate; Early immunosuppressants (azathioprine, methotrexate); Methotrexate bellon; Methotrexate bellon 25mg/ml; Clobetasol propionate + methotrexate; Treatment with systemic therapy (methotrexate); Cyclosporin, methotrexate (gvhd prophylaxis);   D00142
 D02115 
 2件: DHFR, DHFR2   2件: Folate biosynthesis, One carbon pool by folate   33件:
11,
13,
19,
34,
35,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
55,
56,
60,
62,
65,
84,
93,
96,
97,
162,
164,
172,
256,
271,
284,
285,
326,
331
 36   Mizoribine  1件: Mizoribine;   D01392   2件: IMPDH1, IMPDH2   2件: Metabolic pathways, Purine metabolism   8件:
46,
49,
51,
53,
66,
94,
222,
224
 37   Mycophenolate mofetil  17件: Mycophenolate mofetil; Mycophenolate mofetil (cellcept); Mycophenolate mofetil [cellcept]; Mycophenolate mofetil (mmf) 3 g/day; Mycophenolate mofetil 2 g/day; Cellcept (mycophenolate mofetil); Mycophenolate mofetil,methotrexate; Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate); Mycophenolate mofetil (mmf); Mycophenolate mofetil plus lower dose of prednisone; Azathioprine or mycophenolate mofetil; Mycophenolate mofetil orally 1000 mg twice a day (bid); Mycophenolate mofetil, low dose steroid; Prednisolone and mycophenolate mofetil; Mycophenolate mofetil(mmf); Cyclosporine combine with mycophenolate mofetil; Prednisone and mycophenolate mofetil;   D00752
 D05094
 D05095 
 2件: IMPDH1, IMPDH2   1件: Purine metabolism   32件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300
 38   Mycophenolic acid  2件: Mycophenolic acid; Mycophenolic acid mofetil;   D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   34件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
228,
234,
283,
284,
285,
300
 39   NGX267  1件: Ngx267;   -   -   -   1件:
53
 40   Nicotinamide  2件: Nicotinamide; Nicotinamide riboside;   D00036   -   -   8件:
5,
6,
13,
46,
49,
53,
67,
162
 41   Nivolumab  1件: Nivolumab;   D10316   1件: PDCD1   3件: Cell adhesion molecules (CAMs), PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway   10件:
13,
26,
41,
46,
49,
50,
51,
53,
96,
97
 42   Olea europaea leaf  0件:   -   -   -   3件:
13,
49,
53
 43   Olive oil  2件: Freshly-pressed extra virgin olive oil; Olive oil;   D03311   -   -   4件:
13,
49,
53,
96
 44   Omalizumab  3件: Omalizumab; Omalizumab (xolair); Rituximab combined with omalizumab;   D05251   1件: FCER1A   2件: Asthma, Fc epsilon RI signaling pathway   6件:
53,
65,
98,
162,
226,
299
 45   Parsaclisib  1件: Parsaclisib;   D11437   1件: PIK3CD   3件: B cell receptor signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   3件:
35,
53,
61
 46   Phosphate ion  0件:   -   -   -   29件:
2,
3,
11,
12,
13,
28,
36,
46,
49,
51,
53,
60,
62,
65,
70,
78,
81,
83,
90,
96,
97,
164,
235,
256,
283,
284,
285,
286,
299
 47   Pilocarpine  2件: Pilocarpine; Pilocarpine nitrate 5%;   D00525
 D02200
 D05478 
 2件: CHRM2, CHRM3   3件: Cholinergic synapse, Neuroactive ligand-receptor interaction, Salivary secretion   3件:
6,
53,
299
 48   Polysorbate 80  0件:   D01067   -   -   1件:
53
 49   Prasterone  2件: Prasterone; Prasterone (gl701);   D08409   2件: ESR1, ESR2   1件: Estrogen signaling pathway   6件:
49,
53,
83,
86,
96,
113
 50   Prednisone  59件: Prednisone; Prednisone - azathioprine; Prednisone alone; Granulocyte-colony stimulating factor (g-csf) and prednisone; Prednisone/prednisolone; Prednisone acetate; Prednisone, cyclophosphamide; Over encapsulated prednisone; Prednisone and ustekinumab treatment; Prednisone capsules; Prednisone tablets usp, 1 mg; Prednisone tablets usp, 2.5 mg; Prednisone tablets usp, 5 mg; Prednisone tablets, usp; Prednisone therapy and pharmacokinetic; Prednisone treatment; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Prednisone, methylprednisolone,cyclophosphamides; Prednisone (and methylprednisolone); 0 mg prednisone; 5 mg prednisone; Methylprednisone; Prednisone 15 mg; Prednisone 5 mg; Prednisone 7.5 mg; Rayos (delayed-release prednisone); Corticosteroids (prednisone or prednisolone); Cyclophosphamide-prednisone-azathioprine; Oral prednisone 5mg; Prednisone discontinuation; Chinese herb prescription granule plus prednisone; Enalapril valsartan methylprednisone; Hormone (prednisone); Leflunomide 20 mg+prednisone 0.5mg/kg/d; Methylprednisolone (mp) or prednisone (pred); Mycophenolate mofetil plus lower dose of prednisone; Prednisone + inhibace/cozaar; Prednisone and cyclophosphamide; Prednisone arrow 20mg; Prednisone arrow 5 mg; Prednisone in full dose; Prednisone or prednisolone; Prednisone plus cyclophosphamide; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Glucocorticoid (prednisone or prednisolone); Hydroxychloroquine + prednisone; Azathioprine/prednisone; 5-asa, prednisone, azathioprine or remicade; 5-aminosalicylic acid(5-asa) and/or prednisone; Treatment systemic therapy (prednisone); Treatment with systemic therapy (prednisone); Prednisone 0,5 mg/kg orally on alternate days; Prednisone, fk506, mmf; Tacrolimus combined with prednisone; Prednisone acetate tablets; Oral prednisone; Sotatercept with prednisone boost; Prednisone and mycophenolate mofetil; Thalidomide, cyclophosphamide and prednisone;   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   44件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
145,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331
 51   Rebamipide  1件: Rebamipide;   D01121   -   -   4件:
46,
53,
97,
271
 52   Rituximab  52件: Rituximab; Rituximab (rituxan); Mabthera (rituximab); Mabthera or biosimilar rituximab product; Rituximab infusion; Rituximab it; Rituximab iv; Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine; Rituximab (mabthera® or rituxan®).; Rituximab and cyclophosphamide iv; Rituximab (arm a); Rituximab (arm b); Abatacept, rituximab or tocilizumab; Abp 798 - biosimilar to rituximab; Gp2013 - a proposed biosimilar rituximab; Idec-c2b8 (rituximab); Mabthera® (rituximab); Originator rituximab - rituxan ® or mabthera ®; Rituxan (inn: rituximab), brand name in the united states; Rituxan® (rituximab); Rituximab - mabthera; Rituximab [mabthera/rituxan]; Rituximab [mabthera]; Rituximab mabthera; Rituximab, mtx, folic acid; Rituximab, observational study amon patients with active ra; Rituximab-eu+ rituximab-pfizer x 2 courses; Rituximab-pfizer (pf-05280586) x 3 courses; Rituximab-us + rituximab-pfizer x 2 courses; Sait101 (proposed rituximab biosimilar); Individualized dose of rituximab; Rituxan (rituximab); Standard dose of rituximab; Administration of rituximab and methylprednisolone; Rituximab (anti-cd20); Alemtuzumab and rituximab; Bendamustine, rituximab; Mabthera or biosimilar rituximab; Rituximab (mabthera®); Alemtuzumab, rituximab; Dexamethasone and rituximab; Rhtpo in combination with rituximab; Immunosuppressive treatment (eg, rituximab); Rituximab (rtx) and azathioprine (aza); Intravenous rituximab; Combined plasma exchange (pex), rituximab, and corticosteroids; The standard steroid treatment, plasma exchange and rituximab; Rituximab 1g iv; Rituximab combined with omalizumab; Experimental (non immunosuppressive symptomatic treatment (nist) and rituximab); Rituximab/ mabthera; Rituximab or rituximab hyaluronidase human;   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   42件:
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331
 53   Sodium chloride  14件: 0.9% sodium chloride; 0.9% sodium chloride (normal saline); Sodium chloride; Sodium chloride solution; Isotonic sodium chloride solution; 0.9% sodium chloride injection; Physiological serum (sodium chloride); Sodium chloride solvent; Sodium chloride solution 0.9%; 0.9% w/v sodium chloride solution; Sodium chloride (7%); Sodium chloride 0,9%; Sodium chloride 6%; Sodium pyruvate in 0.9% sodium chloride solution;   D02056   -   -   19件:
6,
11,
13,
14,
17,
34,
46,
51,
53,
67,
78,
86,
97,
168,
193,
227,
228,
288,
299
 54   Tacrolimus  13件: Tacrolimus; Tacrolimus capsule; Interferon beta-1b and tacrolimus; Non-mtx dmards (e.g. sulfasalazine, leflunomide, bucillamine, tacrolimus, or mizoribin); Tacrolimus (prograf®); Tacrolimus with methotrexate; Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf; Lcp-tacro (tacrolimus); Rectal tacrolimus; Tacrolimus capsules; Tacrolimus combined with prednisone; Tacrolimus and mmf; Tacrolimus prolonged-release hard capsules;   D00107
 D08556 
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   30件:
2,
11,
13,
36,
46,
49,
50,
51,
53,
60,
61,
62,
65,
66,
85,
86,
95,
96,
97,
113,
151,
158,
164,
222,
224,
226,
228,
283,
284,
299
 55   Tetracycline  4件: Tetracycline; Tetracycline - statin - antimycotic; Amoxicillin and tetracycline; Amoxicillin, metronidazole and tetracycline;   D00201   -   -   5件:
13,
36,
46,
53,
97
 56   Thalidomide  9件: Thalidomide; Thalidomide (drug); Fpf 300 (thalidomide); Melphalan, thalidomide and dexamethasone; Thalidomide pharmion; Thalidomide celgene - 50 mg capsula rigida - uso orale - blister (pvc/pe/aclar/alu) 28 capsule; Thalidomide 100mg; Thalidomide 150mg; Thalidomide, cyclophosphamide and prednisone;   D00754   1件: TNF   4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, NF-kappa B signaling pathway, TNF signaling pathway   18件:
2,
16,
20,
28,
49,
51,
53,
65,
84,
85,
94,
96,
97,
227,
271,
280,
298,
331
 57   Thymosin beta-4  0件:   -   -   -   2件:
36,
53
 58   Tirabrutinib  1件: Tirabrutinib;   -   -   -   2件:
35,
53
 59   Tocilizumab  26件: Tocilizumab; Tocilizumab injection; Tocilizumab (mra-sc); Corticoids+ tocilizumab 8mg/kg/4 weeks; Tocilizumab + glucocorticoids (gcs); Tocilizumab sc; Tocilizumab treatment; Abatacept, rituximab or tocilizumab; Decrease tocilizumab, abatacept; Intra-articular tocilizumab; Mra (tocilizumab); Mra(tocilizumab); Subcutaneous tocilizumab; Tocilizumab (actemra®); Tocilizumab + methotrexate(mtx); Tocilizumab 162 mg; Tocilizumab 162mg/0.9ml jeringa sc; Tocilizumab [roactemra/actemra]; Tocilizumab [roactemra]; Tocilizumab prefilled syringe; Tocilizumab+methotrexate(mtx); Tocilizumab, abatacept; Tocilizumabum; Tocilizumab sc 162 mg/0.9 ml prefilled syringe with safety device (pfs); Inn-tocilizumab; Tocilizumab infusion roacemtra (eu);   D02596   1件: IL6R   3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway   16件:
2,
13,
40,
41,
43,
46,
50,
51,
53,
54,
55,
86,
107,
266,
271,
331
 60   Ustekinumab  32件: Ustekinumab; Prednisone and ustekinumab treatment; Ustekinumab (approximately 6 mg/kg); Ustekinumab 90 milligram (mg); Ustekinumab iv; Ustekinumab sc; Ustekinumab 6 mg/kg; Ustekinumab 90 mg; Subcutaneous ustekinumab; Stelara (ustekinumab); Ustekinumab liquid in prefilled syringe; Ustekinumab 180 mg; Ustekinumab 45 mg; Evaluation of biological predictive factors of clinical response to ustekinumab; Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab; Placebo ustekinumab; Ustekinumab (6 mg/kg); Ustekinumab (90 mg); Ustekinumab 130 mg iv; Ustekinumab 1mg/kg (ip); Ustekinumab 3 mg/kg (ip); Ustekinumab 4.5 mg/kg; Ustekinumab 6 mg/kg (ip); Ustekinumab 90 mg (sc) group 1; Ustekinumab 90 mg (sc) group 2; Ustekinumab 90 mg sc q12w; Ustekinumab 90 mg sc q8w; Ustekinumab approximately 6 mg/kg (iv); Ustekinumab iv - nonresponder - ustekinumab 90mg sc (mp); Ustekinumab iv - responder - ustekinumab 90mg sc (mp); Ustekinumab iv infusion; Ustekinumab sc injection;   D09214   3件: IL12A, IL12B, IL23A   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   16件:
13,
37,
41,
46,
49,
50,
53,
56,
65,
84,
93,
96,
97,
162,
269,
271
 61   Vitamin A  3件: Dietary supplement: vitamin a; Vitamin a; Vitamin ad sig: 1 tablet/tid;   D00069
 D06543 
 -   -   4件:
13,
49,
53,
90
 62   Water  13件: 5% glucose water solution; Water; Pseudoephedrine + 480 ml water; Pseudoephedrine + 50 ml water; 15 o water; Water for injection; 15-o labeled water; Pl 12185/0002 & pl 12185/0005(water for injection); Dextrose, 5% in water; High water intake; Lactose in water; Water for injections; Water for injections, ep;   D00001   -   -   22件:
2,
5,
6,
13,
17,
19,
28,
35,
46,
53,
57,
63,
65,
67,
78,
84,
97,
193,
226,
271,
278,
299
 63   Xylitol  1件: Xylitol;   D00061   -   -   2件:
53,
299
 64   Yellow Fever Vaccine  2件: Yellow fever vaccine; Yellow fever vaccine (17d);   D06347   -   -   7件:
40,
44,
46,
50,
51,
52,
53

先頭へ